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Abstract : Diabetes mellitus （DM） is observed in patients with autoimmune 
pancreatitis （AIP）.  The development of DM in AIP is believed to be due to 
blood ow obstruction of the endocrine gland that accompanies pancreatitis, as 
well as injury to the islets caused by inammation.  The latter is called insuli-
tis and the detailed mechanisms underlying its development are not yet clear.  
The aim of the present study was to elucidate the mechanisms involved in the 
development of insulitis in AIP using aly mice as an animal model of AIP : 
results in aly/aly male mice, as the AIP group, were compared with those in 
aly/+ male mice as a control group.  Mice in both groups were killed between 
16 and 48 weeks of age, and pancreatitis and insulitis were evaluated histologi-
cally.  Inammatory and endocrine cells were evaluated by immunouorescence 
staining with anti-CD4, anti-CD8, anti-CD11b, and anti-CD11c antibodies, as 
well as immunohistochemical analyses using insulin and glucagon antibodies.  
Plasma levels and the pancreatic content of interferon （IFN）-γ （as a Th1-
secreted cytokine） and interleukin （IL）-4 （as a Th2-secreted cytokine） were 
determined.  Pancreatitis was seen in aly/aly mice from 16 weeks of age and it 
developed gradually thereafter.  Insulitis also developed gradually and was seen 
in mice after 24 weeks of age in association with a decrease in the number of 
islets.  CD11c＋ cells and CD4＋ T cells were seen to inltrate into the islets.  
Although the number of β-cells decreased with time, the number of α-cells 
was maintained until mice were 48 weeks of age.  IFN-γ content peaked in 
mice at 16 weeks of age and declined rapidly from 20 weeks.  There were two 
peaks in IL-4 content, one at 16 weeks and the other at 32 weeks, suggesting 
an association between IL-4 content and advanced insulitis after 32 weeks.  In 
conclusion, the results suggest that insulitis in AIP is induced predominantly by 
the inltration of CD11c＋ cells and CD4＋ T cells into the islets, and progres-
sion is facilitated by the imbalance of the activation of Th2 rather than Th1.  
Furthermore, insulitis in AIP predominantly involves β-cells rather than α-cells.
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Introduction
　The involvement of an autoimmune-like mechanism in the development of pancreatitis 
was rst proposed in the 1960s1）.  Further investigations were not able to provide sufcient 
details of specic clinical characteristics or laboratory ndings compared with other types of 
pancreatitis, and thus the condition was not recognized as an independent disease.  Autoim-
mune pancreatitis （AIP） was originally described in Japan 2） and has been established as a 
specic disease entity.  AIP is a unique form of pancreatitis characterized by evidence of the 
involvement of autoimmune mechanisms, such as hypergammaglobulinemia, increased serum 
levels of IgG and IgG4, the presence of autoantibodies, and an effective response to steroid 
therapy.  Other organ involvement in pancreatitis may be observed in patients with AIP. 
Sialadenitis and dacryocystitis are frequently observed, as are sclerosing cholangitis, retroperi-
toneal brosis, and interstitial nephritis.  Furthermore, the involvement of other organs in 
pancreatitis seems to extend systemically to various organs, suggesting that AIP is an IgG4-
related systemic disease 3，4）, with “IgG4-related disease” 5） recognized as a new entity.  In AIP, 
disorders of both pancreatic exocrine and endocrine function are often induced, and many 
patients have either diabetes mellitus （DM） and/or impaired glucose tolerance （IGT）6-9）.
　It has been reported that IGT and DM occur in 42%～ 78% of cases of AIP 10-13）.  In 
addition, in many of these patients steroid therapy not only improves AIP, but also ame-
liorates DM and IGT 14-18）.  The mechanism underlying the development of DM in AIP is 
considered to involve both blood ow obstruction of the endocrine gland （with accompany-
ing formation of exocrine gland brosis） and injury to the pancreatic islets of Langerhan’s 
caused by inammation 19）.  The latter is known as “insulitis”.  Histological evidence suggests 
that the DM is due to direct pancreatic β-cell injury caused by lymphocytes, particularly T 
cells.  The mechanisms underlying the development of DM in AIP may be similar to those 
in type 1 DM （T1DM）.  Although an autoimmune-like mechanism may be responsible for 
DM in AIP in addition to inammation of the exocrine cells, so-called “pancreatitis” in AIP, 
the presence of pathogenic mechanisms remains unclear.  In previous studies using aly mice 
as an animal model of AIP, we  focused mainly on morbidity and other organ involvement 
in AIP, specically exocrine gland injury 20，21）.  In the present study, we elucidated the fea-
tures of and pathogenic mechanisms involved in insulitis in AIP in aly mice.
Materials and Methods
Materials
　Twenty-four male aly/aly mice and 23 male aly/+ mice were purchased from CLEA 
Japan （Shizuoka, Japan）.  Mouse interleukin （IL）-4 and interferon （IFN）-γ immunoassays 
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were purchased from R&D Systems （Minneapolis, MN, USA）.  The polyclonal rabbit anti-
glucagon antibody was obtained from Nichirei Bioscience （Tokyo, Japan）, whereas the 
polyclonal guinea pig anti-insulin antibody was obtained from DAKO （Glostrup, Denmark）. 
The extraction buffer 22）, monoclonal mouse anti-CD4, anti-CD8, anti-CD11b, and anti-CD11c 
antibodies were kindly provided by Drs.  Susumu Ueda and Natsumi Takeyama （Nippon 
Institute for Biological Science, Ome, Japan）.
aly mice
　The characteristic features of adult aly/aly mice are the absence of lymph nodes and Peyer’s 
patches in the jejunum and ileum.  This is a mouse model of immune deciency, with no 
lymphocyte function in vivo, even though T and B cells are present.  These abnormalities 
are governed by the autosomal chromosome single recessive gene alymphoplasia （aly）. 
Inammatory cell permeation of lymphocytes histologically mainly occurs in the pancreas, 
and a pancreatic acinar cell obstacle is accepted, mechanisms of autoimmune abnormalities 
are thought to be associated with the onset and the development of pancreatitis, and we 
have been using it as a naturally developed animal model of pancreatitis.  Although immune 
deciency is seen in male aly/aly mice, similar disorders are not seen in aly/+ mice.  There-
fore, in the present study, we used aly/aly male mice as the AIP group and aly/+ male mice 
as the control （Ctr） group.
Pancreatitis and insulitis in aly mice
　Both aly/aly and aly/+ male mice were purchased at 8 weeks of age.  Mice were main-
tained in a temperature-controlled environment （23℃） under a 12-h light-dark cycle.  Mice 
had free access to high-pressure steam-sterilized food and cooled chlorine-containing water 
that had been boiled.
　The pancreas was removed from mice in both groups at 16, 20, 24, 28, 32, and 46 weeks 
of age.  Briey, after mice had been anesthetized with pentobarbital, a blood sample was 
collected via heart puncture.  Following collection of the blood sample, an abdominal 
incision was made and the pancreas was removed.  Pancreatic tissues from both groups 
were compared at each time point.  The animal protocols used in the present study were 
approved by the Committee for Animal Experimentation of Showa University.
Histologic examination
　For light-microscopic examination, pancreatic tissues were fixed in 10% formaldehyde, 
embedded in paraffin wax and stained with hematoxylin-eosin （HE）.  Pancreatitis was 
evaluated as a disorder of pancreatic exocrine function, whereas insulitis was evaluated as a 
disorder of pancreatic endocrine function.  The severity of the pancreatitis was determined 
quantitatively by evaluating the number of inltrating inammatory cells and vacuolization 
using ImageJ software （National Institutes of Health ［NIH］, Bethesda, MD, USA）.
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Immunouorescent staining
　Immunouorescent staining with anti-CD4, anti-CD8, anti-CD11b, and anti-CD11c antibod-
ies was used to determine inammatory cells in pancreas.  Briey, samples of pancreatic 
tissue were xed and quickly frozen at -70℃ using optimum cutting temperature （OCT） 
compound before being sliced （7μm）.  The tissue slices were stored at -20℃ until they 
were stained using streptavidin-biotin peroxidase complex and mouse anti-CD4, anti-CD8, 
anti-CD11b, and anti-CD11c monoclonal antibodies.
Immunohistochemical staining
　Endocrine cells （i.e. α- and β-cells） were evaluated immunohistochemically for insulin 
and glucagon.  Parafn blocks were stained for insulin using Simple Stain Rat MAX-PO 
（MULTI） （Nichirei Corporation, Tokyo, Japan） and an insulin guinea pig polyclonal anti-
body as the primary antibody, and for glucagon using Simple Stain Mouse MAX-PO （R） 
（Nichirei Corporation） and a glucagon rabbit polyclonal antibody as the primary antibody. 
Based on insulin staining, the number of β-cells and islets in a given area was determined 
using ImageJ software （NIH）.
Serum levels and pancreatic content of IFN-γ and IL-4 level in aly mice
　The pancreatic content of IFN-γ, as a T helper （Th） 1-secreted cytokine, and IL-4, as a 
Th2-secreted cytokine, was determined, as were plasma concentrations of IFN-γ and IL-4. 
Briey, pancreatic tissue samples were homogenized using extraction buffer containing vari-
ous agents to protect against protein degradation, as well as chelating agents.  Cytokine 
activity in the tissue samples was determined using a commercially available protein assay 
（Bio-Rad） and expressed as pg/mg protein.
　Serum levels of IFN-γ and IL-4 were determined by ELISA in plasma obtained by cen-
trifuging the blood samples collected via heart puncture at specied times at 15,000 g for 10 
min at 4℃ and using mouse anti-IFN-γ and anti-IL-4 antibodies.
Statistical analysis
　Statistical analyses were performed using t-tests, with P＜ 0.05 considered signicant.
Results
Body and organ weight in aly mice
　There were significant differences in the body weight of aly/aly （AIP） compared with 
aly/+ （Ctr） mice at 28, 32, and 46 weeks of age （Fig. 1 ; P＜ 0.05）, most likely due to the 
effect of pancreatitis.  Similarly, the pancreas/body weight ratio differed signicantly between 
AIP and Ctr mice at 28, 32, and 46 weeks of age （Fig. 2 ; P＜ 0.05）, again most likely due 
to pancreatitis.
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Histological evaluation of pancreatic tissue
Pancreatitis （HE staining）
　Histological examination of pancreatic sections from AIP mice revealed inflammatory 
cell infiltration and vacuolization in the circumference of small pancreatic ducts from 16 
weeks of age, the absence of pancreatic acinar cells from 24 weeks of age, and, in addi-
tion to inammatory cell inltration, brosis after 28 weeks of age.  The inammatory cell 
inltration increased with age, with extensive inltration and brosis observed in mice at 45 
weeks of age.  In contrast, histological examination of pancreatic sections from 45-week-old 
Ctr mice revealed normal tissue （Fig. 3a, b）.  The number of inammatory cells that had 
Fig. 1.  Body weight of aly mice. There were significant differences between 
the aly/aly mice as a model of autoimmune pancreatitis （AIP） and 
aly/+ （control） mice at 28, 32, and 46 weeks of age. ＊P＜ 0.05.
Fig. 2.  Pancreas/body weight ratio of aly mice. There were significant 
differences between the aly/aly mice as a model of autoimmune 
pancreatitis （AIP） and aly/+ （control） mice at 28, 32, and 46 
weeks of age. ＊P＜ 0.05.
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inltrated the tissue and the degree of vacuolization were determined using ImageJ （NIH）. 
Inammatory cell inltration and vacuolization both increased gradually in AIP mice after 16 
weeks of age, with signicant differences in both parameters observed between the AIP and 
Ctr groups （Fig. 4 ; P＜ 0.05）.
Insulitis （HE staining）
　Insulitis is dened as inammatory cell inltration into the islets.  In the present study, 
inammatory cell inltration into the islet was seen in the AIP group from 24 weeks of age. 
In some tissues, it appeared that the entire islet had been replaced by inammatory cells, 
which is equivalent to insulitis.  The results of HE staining for islets were unclear （Fig. 5）. 
In the AIP group, the number of recognizable islets decreased signicantly compared with 
that in the Ctr group.  Insulitis progressed with time, although it appeared to be slightly 
behind the development of pancreatitis.
Immunouorescent staining
　CD11c＋ cells and CD4＋ T cells predominantly inltrated from the peripheral areas of 
islets to central areas.  There were no CD11b＋ or CD8＋ cells detected in the pancreatic 
tissue （Fig. 6）.
Immunohistochemical staining
　Immunohistochemical staining for insulin revealed the absence of islet β-cells in AIP mice 
from 24 weeks of age.  Furthermore, morphological changes were observed, such as a reduc-
Fig. 3.  Histological changes in the pancreatic tissue of aly/aly mice as a model of autoimmune pancreatitis 
（AIP） and aly/+ （control） mice at （a） 16 and （b） 45 weeks of age. Pancreatitis （hematoxylin-eosin 
［HE］ staining）. （a） Pancreatitis was observed in AIP mice from 16 weeks of age and progressed with 
time. （b） At 45 weeks of age, extensive inflammatory cell infiltration and fibrosis were observed in 
AIP mice. In contrast, in the control group, normal pancreatic tissue was evident at 45 weeks of age.
a
b
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tion in the size of the islets and a greater irregularity in form, in addition to β-cell injury; 
both these observations reect the development of insulitis.  In contrast, islets in the Ctr 
group were round and relatively large （Figs. 7, 9）.  ImageJ analysis of the number of β-cells 
Fig. 4.  Numbers of infiltrating inflammatory cells and vacuolization in 
the pancreatic tissue of aly/aly mice as a model of autoimmune 
pancreatitis （AIP） and aly/+ （control） mice. Infiltration of 
inflammatory cells, predominantly lymphocytes, was evident in 
the AIP and increased, along with vacuolization, in mice after 16 
weeks of age. There were significant differences in the number of 
infiltrating cells and vacuolization counts between the AIP and 
control groups at 28, 32, and 46 weeks of age. Data are the mean
±SEM. ＊P＜ 0.05.
Fig. 5.  Histological changes in the pancreatic tissue of aly/aly mice as a 
model of autoimmune pancreatitis （AIP） and aly/+ （control） mice 
（hematoxylin-eosin staining）. Insulitis （arrow） was evident in the 
AIP group at 24 weeks of age.
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Fig. 6.  Immunofluorescent staining with anti-CD4, anti-CD8, anti-CD11b, and anti-CD11c 
antibodies. Infiltration of CD11c＋ cells and CD4＋ cells was seen predominantly 
from peripheral areas of the islets to central areas.
Fig. 7.  Immunohistochemical staining for insulin revealed the absence of 
β-cells in islets from aly/aly mice, as a model of autoimmune 
pancreatitis （AIP）, at 24 weeks of age. Furthermore, morphological 
changes were seen in the islets, such as a reduction in size and 
irregular shape, reflecting the development of insulitis.
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Fig. 8.  Immunohistochemical staining for glucagon revealed no significant 
differences in α-cells between the aly/aly mice as a model of 
autoimmune pancreatitis （AIP） and aly/+ （control） mice, with little 
evidence of α-cell damage.
Fig. 9.  Islets in aly/aly mice as a model of autoimmune pancreatitis （AIP） 
and aly/+ （control） mice. In the control group, the islets appeared 
large and round ; in contrast, in the AIP group the islets were small 
and irregular in shape.
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and islets conrmed a signicant decrease in both in the AIP group compared with Ctr 
group.  The decrease in the number of β-cells and islets in the AIP group increased with 
time （Fig. 10）.
　Immunohistochemical staining for glucagon revealed no significant differences in the 
number of α-cells, which exist around the edges of islets, between the AIP and Ctr groups, 
although there was evidence of some α-cells damage （Fig. 8）.  When the ratio of α-cells 
and β-cells within islets was evaluated between the AIP group and a control group, there 
was a signicant difference in β-cells, but no difference in α-cells.  Regarding for insulitis in 
AIP group, the β-cell was mainly received the obstacle.
Pancreatic content and serum levels of IFN-γ and IL-4
　Pancreatic IFN-γ content peaked in the AIP group between 8 and 16 weeks of age, and 
rapidly declined after 24 weeks of age.  This was similar to the results obtained in the Ctr 
group （Fig. 11）.  In contrast, there were two peaks in pancreatic IL-4 content in the AIP 
group, one in mice at 16 weeks of age and the second at 32 weeks of age （Fig. 12）.
Discussion
　The term “insulitis” was rst proposed by von Meyenburg in 1940.  He reported on the 
postmortem ndings in a woman who had died of diabetic ketoacidosis : specically, there 
was a decrease in the number of islets in addition to morphological changes, such as acinar 
cell degradation and inammatory cell inltration into the islets.  von Meyenburg termed 
inflammatory cell infiltration into the islets as insulitis 23）.  In 1965, Gepts reported that 
Fig. 10.  The number of β-cells in the islets of aly/aly mice as 
a model of autoimmune pancreatitis （AIP） and aly/+ 
（control） mice. There were significantly fewer β-cells 
in islets from the AIP group, and their numbers 
decreased further with time. Data are the mean±
SEM. ＊P＜ 0.05.
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islets of many patients with T1DM exhibited signs of insulitis 24）, giving rise to the autoim-
munity theory of T1DM.  With the discovery of self-antibodies, such as islet antibodies, the 
coexistence of other autoimmune diseases, and a relationship with human leukocyte antigen 
（HLA） antigens, it seemed clear that T1DM was an autoimmune disease.  The existence 
of insulitis, which results from inammatory cell （primarily lymphocyte） inltration into the 
islets, became the basis of the autoimmunity theory.  Foulis recognized insulitis in 78% of 
Fig. 11.  Interferon （IFN）-γ levels in pancreatic homogenates 
of aly/aly mice as a model of autoimmune pancreatitis 
（AIP） and aly/+ （control） mice. Pancreatic levels of 
IFN-γ peaked in the AIP group at 16 weeks of age 
and declined rapidly after 20 weeks of age.
Fig. 12.  Interleukin （IL）-4 levels in pancreatic homogenates of 
aly/aly mice as a model of autoimmune pancreatitis 
（AIP） and aly/+ （control） mice. Pancreatic levels of 
IL-4 peaked twice in AIP mice : once at 16 weeks of 
age and then again at 32 weeks of age.
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pancreatic tissues from patients with T1DM who died young, and interpreted these ndings 
to mean that β-cell destruction was caused by an immunological mechanism 25）.  Even today, 
T1DM is thought of as an autoimmune disease, and insulitis may be one of the autoim-
munological mechanisms involved.
　In AIP, disorders of pancreatic exocrine and endocrine function are often present, and 
DM and IGT are observed in many cases 5-8）; this is believed to be due to the effect of 
both blood flow obstruction of the endocrine gland accompanying formation of exocrine 
gland brosis and insulitis18）.  We have used aly mice as a mouse model of AIP in previous 
studies 19，20）.  In the present study, we elucidated the morbidity and pathogenic mechanism of 
insulitis in AIP using aly mice.
　We found that insulitis appeared after pancreatitis, increasing in severity with age, and 
there was evidence of inammatory cell inltration into the islets.  On the basis of these 
observations, we assume that the inammatory cell inltration and brosis associated with 
pancreatitis causes islet ischemia, giving rise to insulitis secondary to pancreatitis.  One 
would expect that the effects of inammation associated with pancreatitis would affect all 
cells in the islets uniformly.  However, when we analyzed the endocrine cells in the islets, 
we found minimal effects on α-cells.  In contrast, the β-cells were markedly involved, as 
evidenced by reductions in β-cell numbers, modications, and their eventual absence from 
the islets altogether.  These findings are consistent with those of Tanaka, who found a 
decreased number of β-cells in islets from patients with AIP 5，8）.  Furthermore, immunouo-
rescent staining of the pancreas revealed inltration of CD11c＋ cells and CD4＋ T cells into 
the islets, implying the involvement of an autoimmune mechanism in the development of 
insulitis （see below）.  Therefore, although insulitis is considered to be an event secondary to 
advancing pancreatitis, the contribution of β-cells damage to this process appears consider-
able.
　Although pancreatic DM occurs as a result of decreased endocrine function of the 
pancreas with the progression of pancreatic disease, the obstacle not only of insulin but 
the secretion of glucagon is carried out in response to the inuence of a primary disease. 
Therefore, pancreatic DM presents with different characteristics and clinical ndings com-
pared with the usual DM, including impaired insulin secretion and glycemic control.  So-
called “pancreatic DM” is caused by chronic pancreatitis, pancreatic tumors, and acute 
pancreatitis, and it may develop after resection of the pancreas.  The DM in AIP is also 
pancreatic DM, because glucose tolerance worsens in connection with pancreatitis.  However, 
because insulitis is involved in the etiology of DM in AIP, insulitis is considered a different 
disease from the usual pancreatic DM in that it primarily involves damage to β-cells.  In 
addition, in the present study, although there was a signicant reduction in β-cells in AIP, 
the α-cell population was unaffected, so insulitis is considered to be inammation specic to 
β-cells.  Over the longer term, it is possible that AIP will progress to chronic pancreatitis, 
in which there are reductions in both β- and α-cells depending on the degree of brosis in 
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the pancreas ; this then mimics the pattern seen in pancreatic DM with increasing brosis 
of the pancreas.  In the present study, the α-cell population was unaffected in the AIP 
group at 46 weeks of age.  However, because the involvement of α-cells may appear in the 
mouse at much later stages （i.e. age）, as in humans, we are currently undertaking experi-
ments to evaluate pancreatic tissue in mice at an advanced age.
　Immunouorescent staining in the present study revealed inltration of CD11c＋ cells and 
CD4＋ T cells in AIP.  CD11c is a membrane antigen characteristic of leukocytes that is 
observed mainly in macrophages, monocytes, and dendritic cells as antigen-presenting cells 
（APC）.  It participates in cell adhesion and phagocytosis.  In terms of the development 
of insulitis, we assume that the mechanism involves antigen presentation by CD11c＋ cells, 
followed by the migration of CD4＋ T cells, which results in inammation.  CD4 is a typical 
membrane antigen of Th cells, which are classied into Th1 and Th2 cells on the basis of 
the types of cytokines they produce : Th1 cells produce IFN-γ and have cytotoxic activities, 
whereas Th2 cells produce IL-4 and are involved in antibody production 25）.  Imbalances 
in the Th1/ Th2 ratio are indicative of autoimmune disease, with a shift to predominantly 
Th1 responses related to organ-specic autoimmune disease, and a shift to predominantly 
Th2 responses related to systemic autoimmune disease 26）.  For example, T1DM, a disease 
that similarly causes insulitis, is an organ-specic autoimmune disease of pancreatic β-cells 
in which the DM arises because of the destruction of β-cells, which produce insulin.  The 
mechanism involved is believed to be CD4＋ T cell activation of cytotoxic （CD8＋） T cells, 
which then damage the pancreatic β-cells.  Using NOD mice, it has been shown that Th1 
activation is involved in the activation of CD4＋ T cells 27-31）.  Evaluation of serum IFN-γ 
and IL-4 levels in the AIP group revealed an increase in IFN-γ concentrations in mice 
at the earlier ages, suggesting that Th1 responses were contributing to the development of 
pancreatitis.  However, IFN-γ levels declined rapidly in AIP mice after 24 weeks of age 
to leve ls seen in the control group.  Conversely, a double peak in pancreatic IL-4 levels 
was seen in the AIP group, at 16 and 32 weeks of age.  We assume that this indicates the 
activation of Th2 responses after 32 weeks of age that contributed to the progression of 
insulitis.  Staining for CD8＋ cells as cytotoxic T cells was negative in the AIP group.  On 
the basis of these ndings, we believe that there are differences between insulitis of AIP 
and that of T1DM in terms of the underlying immunological mechanisms, although both 
diseases exhibit similar β-cell injury.
　In conclusion, we believe the insulitis in AIP is secondary to advancing pancreatitis, but 
that endocrine disorders, such as DM, arise as a result of a decrease in β-cells.  The mecha-
nism may involve CD11c＋ cells, which are AIP, triggering the migration of CD4＋ T cells 
to induce an inammatory response.  Moreover, we also assume that a shift in the Th1/Th2 
balance towards Th2 activation contributes considerably to the development of insulitis in 
AIP.  Th2 responses are related to systemic autoimmune disease and we consider that this 
is the main cause of insulitis in AIP.  In recent years, it has been proposed that AIP is an 
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IgG4-related systemic disease （an IgG4-related disease 5））.  This contention is supported by 
the results of the present study showing activation of Th2 responses in AIP.  Although the 
DM that arises as a result of insulitis in AIP is similar to T1DM in terms of β-cell destruc-
tion, it differs from so-called “pancreatic DM”, in which both α- and β-cells are involved.
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